Society of Nuclear Medicine and Molecular Imaging
@snm-mi.bsky.social
An international scientific and medical organization dedicated to raising public awareness about molecular imaging. Learn more at https://linktr.ee/snmmi
Pre-treating a tumor before delivering alpha-radioimmunotherapy has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer.
jnm.snmjournals.org/content/earl...
jnm.snmjournals.org/content/earl...
November 10, 2025 at 3:27 PM
Pre-treating a tumor before delivering alpha-radioimmunotherapy has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer.
jnm.snmjournals.org/content/earl...
jnm.snmjournals.org/content/earl...
It's November — the season of giving thanks — for a new issue of JNM! Here's what's inside this month: 🧵👇
jnm.snmjournals.org
jnm.snmjournals.org
November 4, 2025 at 3:27 PM
It's November — the season of giving thanks — for a new issue of JNM! Here's what's inside this month: 🧵👇
jnm.snmjournals.org
jnm.snmjournals.org
Have you been hearing about Pluvicto in the news? Our patient accounts share more about what it is and how it works:
You may have been hearing about something called "Pluvicto" in the news lately, especially as it relates to prostate cancer. Pluvicto is the commercial name for a nuclear medicine therapy called PSMA-targeted therapy. Let's learn more 🧵👇
November 4, 2025 at 3:26 PM
Have you been hearing about Pluvicto in the news? Our patient accounts share more about what it is and how it works:
Reposted by Society of Nuclear Medicine and Molecular Imaging
A new approach to PET #imaging published by @snm-mi.bsky.social offers a promising way for physicians to identify patients at risk for poor functional recovery after a #heartattack. #nuclearmedicine
PET imaging reveals which patients will (or will not) recover after heart attack
CXCR4 PET/CT imaging of inflammation predicts recovery, guides therapy
healthcare-in-europe.com
October 29, 2025 at 11:42 AM
A new approach to PET #imaging published by @snm-mi.bsky.social offers a promising way for physicians to identify patients at risk for poor functional recovery after a #heartattack. #nuclearmedicine
Heart attacks affect nearly one million Americans each year, but what happens after—the healing process—is less well understood. A new PET imaging technique has changed that. Read more in this month’s JNM: jnm.snmjournals.org/content/earl...
October 23, 2025 at 7:29 PM
Heart attacks affect nearly one million Americans each year, but what happens after—the healing process—is less well understood. A new PET imaging technique has changed that. Read more in this month’s JNM: jnm.snmjournals.org/content/earl...
Reposted by Society of Nuclear Medicine and Molecular Imaging
🚀 Don’t Miss Your Chance to Apply!
The Alavi Mars Shot Research Awards through SNMMI offer 5 grants of $110,000 each to advance infection & inflammation imaging.
Apply by Oct 30, 2025!
sites.snmmi.org/MarsShot/?_z...
The Alavi Mars Shot Research Awards through SNMMI offer 5 grants of $110,000 each to advance infection & inflammation imaging.
Apply by Oct 30, 2025!
sites.snmmi.org/MarsShot/?_z...
Home
sites.snmmi.org
October 15, 2025 at 12:00 PM
🚀 Don’t Miss Your Chance to Apply!
The Alavi Mars Shot Research Awards through SNMMI offer 5 grants of $110,000 each to advance infection & inflammation imaging.
Apply by Oct 30, 2025!
sites.snmmi.org/MarsShot/?_z...
The Alavi Mars Shot Research Awards through SNMMI offer 5 grants of $110,000 each to advance infection & inflammation imaging.
Apply by Oct 30, 2025!
sites.snmmi.org/MarsShot/?_z...
Today for Nuclear Medicine Week, we wanted to give a special shoutout to the 326 nuclear pharmacists who are key in the advancement of our field - particularly for increased access to theranostics. Thank you for your vital contributions!
October 10, 2025 at 2:57 PM
Today for Nuclear Medicine Week, we wanted to give a special shoutout to the 326 nuclear pharmacists who are key in the advancement of our field - particularly for increased access to theranostics. Thank you for your vital contributions!
From atoms to AI-provided answers? The SNMMI AI Task Force is exploring how artificial intelligence can help physician workflow. What task would you give to AI for more patient face time? Let us know 👇
October 8, 2025 at 3:17 PM
From atoms to AI-provided answers? The SNMMI AI Task Force is exploring how artificial intelligence can help physician workflow. What task would you give to AI for more patient face time? Let us know 👇
Happy Nuclear Medicine Week! Nuclear medicine is transforming the way we understand, diagnose, and treat disease. This year's theme -- "From Atoms to Answers" -- celebrates the members of this field from the lab to patients' bedsides.
snmmi.org/Web/News/Art...
snmmi.org/Web/News/Art...
From Atoms to Answers Celebrating the Power of Nuclear Medicine
Happy Nuclear Medicine Week! Nuclear medicine is transforming the way we understand, diagnose, and treat disease. This year's theme -- "From Atoms to Answers" -- celebrates the members of this field,...
snmmi.org
October 6, 2025 at 4:31 PM
Happy Nuclear Medicine Week! Nuclear medicine is transforming the way we understand, diagnose, and treat disease. This year's theme -- "From Atoms to Answers" -- celebrates the members of this field from the lab to patients' bedsides.
snmmi.org/Web/News/Art...
snmmi.org/Web/News/Art...
Join Us in Celebrating Nuclear Medicine Week!
It's time to recognize all the hard work this community does. Join us by sharing your stories, photos, and videos of your work and celebrations!
It's time to recognize all the hard work this community does. Join us by sharing your stories, photos, and videos of your work and celebrations!
October 6, 2025 at 2:23 PM
Join Us in Celebrating Nuclear Medicine Week!
It's time to recognize all the hard work this community does. Join us by sharing your stories, photos, and videos of your work and celebrations!
It's time to recognize all the hard work this community does. Join us by sharing your stories, photos, and videos of your work and celebrations!
Not in the mood for scary stories this spooky season? That's ok, because the October issue of JNM is here instead! Grab your favorite fall drink, curl up by the fire, and dig into some new research: jnm.snmjournals.org/content/66/10
October 1, 2025 at 9:34 PM
Not in the mood for scary stories this spooky season? That's ok, because the October issue of JNM is here instead! Grab your favorite fall drink, curl up by the fire, and dig into some new research: jnm.snmjournals.org/content/66/10
A new PET tracer provides insight into how spinal cord injuries affect both the spinal cord and the brain. This new tracer identifies synapse loss, providing molecularly unique and complementary information to other imaging methods.
Read more: jnm.snmjournals.org/content/66/9...
Read more: jnm.snmjournals.org/content/66/9...
September 23, 2025 at 2:23 PM
A new PET tracer provides insight into how spinal cord injuries affect both the spinal cord and the brain. This new tracer identifies synapse loss, providing molecularly unique and complementary information to other imaging methods.
Read more: jnm.snmjournals.org/content/66/9...
Read more: jnm.snmjournals.org/content/66/9...
Reposted by Society of Nuclear Medicine and Molecular Imaging
Nine Takeaways from New Guidelines on PET Myocardial Perfusion Imaging
www.diagnosticimaging.com/view/nine-ta...
#radiology #RadRes #NuclearMedicine
www.diagnosticimaging.com/view/nine-ta...
#radiology #RadRes #NuclearMedicine
September 19, 2025 at 11:22 AM
Nine Takeaways from New Guidelines on PET Myocardial Perfusion Imaging
www.diagnosticimaging.com/view/nine-ta...
#radiology #RadRes #NuclearMedicine
www.diagnosticimaging.com/view/nine-ta...
#radiology #RadRes #NuclearMedicine
Early and accurate diagnosis of coronary artery disease is critical for improved patient outcomes. @asnc.bsky.social, @eanm.org, ACNM, and SNMMI have developed new guidelines for 18F-flurpiridaz PET myocardial perfusion imaging (MPI) and blood flow quantitation.
snmmi.org/Web/News/Art...
snmmi.org/Web/News/Art...
New International Guideline Provides Expert Guidance for PET Imaging of Patients with Coronary Arter
The Society of Nuclear Medicine and Molecular Imaging (SNMMI), American Society of Nuclear Cardiology (ASNC), European Association of Nuclear Medicine (EANM), and American College of Nuclear Medicine ...
snmmi.org
September 19, 2025 at 1:18 PM
Early and accurate diagnosis of coronary artery disease is critical for improved patient outcomes. @asnc.bsky.social, @eanm.org, ACNM, and SNMMI have developed new guidelines for 18F-flurpiridaz PET myocardial perfusion imaging (MPI) and blood flow quantitation.
snmmi.org/Web/News/Art...
snmmi.org/Web/News/Art...
For the first time ever, a rare malignant tumor responds to treatment. Read more below, and check out the full article in this month's @journalofnucmed.bsky.social:
jnm.snmjournals.org/content/66/9...
jnm.snmjournals.org/content/66/9...
September 18, 2025 at 3:25 PM
For the first time ever, a rare malignant tumor responds to treatment. Read more below, and check out the full article in this month's @journalofnucmed.bsky.social:
jnm.snmjournals.org/content/66/9...
jnm.snmjournals.org/content/66/9...
SNMMI presented a Joint Symposium at the American Thyroid Association Annual Meeting on September 12. Drs. Mehdi Djekidel (far left) & Seza Gulec (far right) along with ATA members held a panel discussion on best practices related to radioactive iodine treatment of thyroid cancer
September 17, 2025 at 9:14 PM
SNMMI presented a Joint Symposium at the American Thyroid Association Annual Meeting on September 12. Drs. Mehdi Djekidel (far left) & Seza Gulec (far right) along with ATA members held a panel discussion on best practices related to radioactive iodine treatment of thyroid cancer
Two molecular targets have emerged as promising candidates for the diagnosis and treatment of endometrial cancer: Human epidermal growth factor 2 (HER2) and cluster of differentiation 24 (CD24). jnm.snmjournals.org/content/earl...
September 5, 2025 at 2:08 PM
Two molecular targets have emerged as promising candidates for the diagnosis and treatment of endometrial cancer: Human epidermal growth factor 2 (HER2) and cluster of differentiation 24 (CD24). jnm.snmjournals.org/content/earl...
Happy September! Whether you're already missing summer or are ready for fall, JNM is always in season. Here are this month's highlights: jnm.snmjournals.org/content/66/9
Journal of Nuclear Medicine: 66 (9)
jnm.snmjournals.org
September 3, 2025 at 5:17 PM
Happy September! Whether you're already missing summer or are ready for fall, JNM is always in season. Here are this month's highlights: jnm.snmjournals.org/content/66/9
New in Uptake: PET Amyloid Quantitation Methods for Degree of Amyloid Burden
Explore how Z-Scores, Standardized Uptake Value Ratios, and Centiloid Scaling are used. Learn more with our infographic below, or read the full article on our website:
snmmi.org/Web/News/Art...
Explore how Z-Scores, Standardized Uptake Value Ratios, and Centiloid Scaling are used. Learn more with our infographic below, or read the full article on our website:
snmmi.org/Web/News/Art...
August 28, 2025 at 5:28 PM
New in Uptake: PET Amyloid Quantitation Methods for Degree of Amyloid Burden
Explore how Z-Scores, Standardized Uptake Value Ratios, and Centiloid Scaling are used. Learn more with our infographic below, or read the full article on our website:
snmmi.org/Web/News/Art...
Explore how Z-Scores, Standardized Uptake Value Ratios, and Centiloid Scaling are used. Learn more with our infographic below, or read the full article on our website:
snmmi.org/Web/News/Art...
A 5-minute Basal Cell Carcinoma diagnosis is within our reach. A topical fluorescent molecular contrast agent called PARPi-FL can detect basal cell carcinoma through intact skin in as little as 5 minutes in ex vivo human tissue. 🧵👇https://jnm.snmjournals.org/content/66/8/1197
August 21, 2025 at 3:33 PM
A 5-minute Basal Cell Carcinoma diagnosis is within our reach. A topical fluorescent molecular contrast agent called PARPi-FL can detect basal cell carcinoma through intact skin in as little as 5 minutes in ex vivo human tissue. 🧵👇https://jnm.snmjournals.org/content/66/8/1197
NEW from @journalofnucmed.bsky.social: Men with biochemically resistant prostate cancer who undergo PSMA PET/CT before salvage radiotherapy have improved survival rates over those who do not.
Read more here 👇🧵
jnm.snmjournals.org/content/66/8...
Read more here 👇🧵
jnm.snmjournals.org/content/66/8...
August 13, 2025 at 1:21 PM
NEW from @journalofnucmed.bsky.social: Men with biochemically resistant prostate cancer who undergo PSMA PET/CT before salvage radiotherapy have improved survival rates over those who do not.
Read more here 👇🧵
jnm.snmjournals.org/content/66/8...
Read more here 👇🧵
jnm.snmjournals.org/content/66/8...
SNMMI is proud to launch the Global Radiopharmaceutical Trials Finder. With the help of AI, SNMMI is addressing that gap, bringing nuclear medicine care to your fingertips. Start by answering 2 easy questions: disease area and zip code: snmmi.org/Web/News/Art...
SNMMI Launches Global Radiopharmaceutical Trial Finder
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is proud to announce the launch of the Global Radiopharmaceutical Trial Finder a revolutionary, AI-powered platform designed to help resea...
snmmi.org
August 11, 2025 at 5:22 PM
SNMMI is proud to launch the Global Radiopharmaceutical Trials Finder. With the help of AI, SNMMI is addressing that gap, bringing nuclear medicine care to your fingertips. Start by answering 2 easy questions: disease area and zip code: snmmi.org/Web/News/Art...
Congratulations David Gilmore, Ed.D., CNMT, RT(R)(N) on receiving the 2025 SNMMI-TS Lifetime Achievement Award for Transformative Contributions to Nuclear Medicine Technology. Read more about his work here: snmmi.org/Web/News/Art...
David Gilmore Receives 2025 SNMMI-TS Lifetime Achievement Award for Transformative Contributions to
David Gilmore, EdD, CNMT, NCT, RT(R)(N), FSNMMI-TS, has been named the recipient of the 2025 SNMMI-TS Lifetime Achievement Award.
snmmi.org
August 5, 2025 at 4:49 PM
Congratulations David Gilmore, Ed.D., CNMT, RT(R)(N) on receiving the 2025 SNMMI-TS Lifetime Achievement Award for Transformative Contributions to Nuclear Medicine Technology. Read more about his work here: snmmi.org/Web/News/Art...
Summer may be winding down but the
@journalofnucmed.bsky.social
is hot off the presses! Check out these highlights: 🧵👇
jnm.snmjournals.org/content/66/8
@journalofnucmed.bsky.social
is hot off the presses! Check out these highlights: 🧵👇
jnm.snmjournals.org/content/66/8
August 4, 2025 at 2:24 PM
Summer may be winding down but the
@journalofnucmed.bsky.social
is hot off the presses! Check out these highlights: 🧵👇
jnm.snmjournals.org/content/66/8
@journalofnucmed.bsky.social
is hot off the presses! Check out these highlights: 🧵👇
jnm.snmjournals.org/content/66/8
Novel Radioimmunotherapy Eradicates Cancer Stem Cells in Ovarian Cancer Model
A new radioimmunotherapy has successfully eliminated cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the gold standard.
Read here: jnm.snmjournals.org/content/66/7...
A new radioimmunotherapy has successfully eliminated cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the gold standard.
Read here: jnm.snmjournals.org/content/66/7...
July 28, 2025 at 1:51 PM
Novel Radioimmunotherapy Eradicates Cancer Stem Cells in Ovarian Cancer Model
A new radioimmunotherapy has successfully eliminated cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the gold standard.
Read here: jnm.snmjournals.org/content/66/7...
A new radioimmunotherapy has successfully eliminated cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the gold standard.
Read here: jnm.snmjournals.org/content/66/7...